1. Home
  2. NEXT vs AAPG Comparison

NEXT vs AAPG Comparison

Compare NEXT & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NextDecade Corporation

NEXT

NextDecade Corporation

HOLD

Current Price

$7.19

Market Cap

2.0B

Sector

Energy

ML Signal

HOLD

AAPG

Ascentage Pharma Group International American Depository Shares

HOLD

Current Price

$19.00

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEXT
AAPG
Founded
2010
2009
Country
United States
China
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.0B
IPO Year
2014
2024

Fundamental Metrics

Financial Performance
Metric
NEXT
AAPG
Price
$7.19
$19.00
Analyst Decision
Hold
Strong Buy
Analyst Count
2
5
Target Price
$8.00
$48.40
AVG Volume (30 Days)
2.8M
3.7K
Earning Date
05-01-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$290.34
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.75
$16.36
52 Week High
$11.23
$48.45

Technical Indicators

Market Signals
Indicator
NEXT
AAPG
Relative Strength Index (RSI) 51.89 55.27
Support Level $6.93 $18.56
Resistance Level $8.36 $20.40
Average True Range (ATR) 0.33 0.42
MACD 0.07 0.15
Stochastic Oscillator 98.25 92.75

Price Performance

Historical Comparison
NEXT
AAPG

About NEXT NextDecade Corporation

NextDecade Corp is a Houston-based energy company engaged in construction and development activities related to the liquefaction of natural gas, the sale of LNG, and the capture and storage of CO2 emissions. The group is constructing and developing a natural gas liquefaction and export facility located in the Rio Grande Valley near Brownsville, Texas (the Rio Grande LNG Facility). It also engaged in NEXT Carbon Solutions, advancing proprietary processes to lower the cost of utilizing carbon capture and storage (CCS) and help companies reduce their emissions and achieve their clean energy goals.

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies and currently has seven drug candidates in pipeline under research. The company's geographical segments include the United States and Mainland China.

Share on Social Networks: